Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Systemic Effects of Epidural Methylprednisolone Injection on Glucose Tolerance in Diabetic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01420497
Recruitment Status : Completed
First Posted : August 19, 2011
Last Update Posted : August 19, 2011
Sponsor:
Information provided by (Responsible Party):
zufferey Pascal, Centre Hospitalier Universitaire Vaudois

Brief Summary:
Several studies have shown that in diabetic patients, the glycemic profile was disturbed after intra-articular injection of corticosteroids. Little is known about the impact of epidural injection in such patients. The goal of this study was double, at first comparing the glycaemic profile in diabetic patients after a unique injection of 80 mg of acetate methylprednisolone either intra-articular or epidural, secondly to compare the amount of systemic diffusion of the drug the after both procedures.

Condition or disease Intervention/treatment Phase
Diabetes Healthy Drug: intra-articular infiltration Drug: epidural infiltration Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 25 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Study Start Date : August 2008
Actual Primary Completion Date : September 2008
Actual Study Completion Date : June 2010

Arm Intervention/treatment
Active Comparator: methylprednisolone,infiltration Drug: intra-articular infiltration
intra articular infiltration

Active Comparator: epidural injection Drug: epidural infiltration
epidural infiltration




Primary Outcome Measures :
  1. glycemic values, [ Time Frame: day 0 to day 15 ]

Secondary Outcome Measures :
  1. urinary excretion rate [ Time Frame: day 0 to day 15 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • diabetes stable for more than ten days
  • no contraindication for steroids
  • lumbar stenosis
  • articular pain

Exclusion Criteria:

  • unstable diabetes
  • renal insufficiency

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01420497


Locations
Layout table for location information
Switzerland
CHUV
Lausanne, VD, Switzerland, 1001
Sponsors and Collaborators
Centre Hospitalier Universitaire Vaudois
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: zufferey Pascal, md, Centre Hospitalier Universitaire Vaudois
ClinicalTrials.gov Identifier: NCT01420497    
Other Study ID Numbers: gylperi
First Posted: August 19, 2011    Key Record Dates
Last Update Posted: August 19, 2011
Last Verified: August 2011
Keywords provided by zufferey Pascal, Centre Hospitalier Universitaire Vaudois:
methylprednisolone
intra articular infiltration
glycemia
epidural infiltration
diabetes